- Home
- MRVI vs NGS Comparison
MRVI vs NGS Comparison
Compare MRVI & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- NGS
- Stock Information
- Founded
- MRVI 2014
- NGS 1998
- Country
- MRVI United States
- NGS United States
- Employees
- MRVI N/A
- NGS N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- NGS Oilfield Services/Equipment
- Sector
- MRVI Health Care
- NGS Energy
- Exchange
- MRVI Nasdaq
- NGS Nasdaq
- Market Cap
- MRVI 350.1M
- NGS 305.2M
- IPO Year
- MRVI 2020
- NGS 2002
- Fundamental
- Price
- MRVI $2.42
- NGS $26.20
- Analyst Decision
- MRVI Hold
- NGS Strong Buy
- Analyst Count
- MRVI 10
- NGS 2
- Target Price
- MRVI $5.84
- NGS $32.50
- AVG Volume (30 Days)
- MRVI 1.5M
- NGS 58.3K
- Earning Date
- MRVI 08-11-2025
- NGS 08-11-2025
- Dividend Yield
- MRVI N/A
- NGS 1.53%
- EPS Growth
- MRVI N/A
- NGS 33.85
- EPS
- MRVI N/A
- NGS 1.42
- Revenue
- MRVI $219,830,000.00
- NGS $164,109,000.00
- Revenue This Year
- MRVI N/A
- NGS $9.75
- Revenue Next Year
- MRVI $7.23
- NGS $14.27
- P/E Ratio
- MRVI N/A
- NGS $18.41
- Revenue Growth
- MRVI N/A
- NGS 14.77
- 52 Week Low
- MRVI $1.67
- NGS $16.73
- 52 Week High
- MRVI $9.60
- NGS $29.74
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- NGS 57.40
- Support Level
- MRVI $2.28
- NGS $25.05
- Resistance Level
- MRVI $2.47
- NGS $26.54
- Average True Range (ATR)
- MRVI 0.14
- NGS 1.08
- MACD
- MRVI -0.01
- NGS 0.13
- Stochastic Oscillator
- MRVI 27.45
- NGS 81.67
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.